Sustained-Release Griffithsin Nanoparticle-Fiber Composites against HIV-1 and HSV-2 Infections

Human immunodeficiency virus (HIV-1) and herpes simplex virus 2 (HSV-2) affect hundreds of millions of people worldwide. The antiviral lectin, Griffithsin (GRFT), has been shown to be both safe and efficacious against HSV-2 and HIV-1 infections in vivo. The goal of this work was to develop a multila...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Control Release
Main Authors: Tyo, Kevin M., Lasnik, Amanda B., Zhang, Longyun, Mahmoud, Mohamed, Jenson, Alfred B., Fuqua, Joshua L., Palmer, Kenneth E., Steinbach-Rankins, Jill M.
格式: Artigo
語言:Inglês
出版: 2020
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7170769/
https://ncbi.nlm.nih.gov/pubmed/32035194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2020.02.006
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍